
Bioorganic and Medicinal Chemistry Letters p. 127 - 132 (1999)
Update date:2022-08-05
Topics:
Reiter, Lawrence A.
Rizzi, James P.
Pandit, Jayvardan
Lasut, Michael J.
McGahee, Shunda M.
Parikh, Vinod D.
Blake, James F.
Danley, Dennis E.
Laird, Ellen R.
Lopez-Anaya, Arturo
Lopresti-Morrow, Lori L.
Mansour, Mahmoud N.
Martinelli, Gary J.
Mitchell, Peter G.
Owens, Brian S.
Pauly, Thomas A.
Reeves, Lisa M.
Schulte, Gayle K.
Yocum, Sue A.
Through the use of empirical and computational methods, phosphinate- based inhibitors of MMP-1 and MMP-13 that bind into the S2 pocket of these enzymes were designed. The synthesis and testing of 2 suggested that binding was occuring as hypothesized. Structure determination of a co-crystal of 2 bound to the catalytic domain of MMP-1 confirmed the binding mode. Substituents binding into S2, S1', S2' and S3', were optimized yielding compounds with low double-digit nM IC50's against these enzymes.
View MoreHebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
JIANGXI ZHANGFENG CHEMICAL CO., LTD.
Contact:+86-0799-3413066
Address:Xiyuan village, Xiabu Town, Xiangdong District
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
Contact:86-10-62983737; +86-10-51287608
Address:4/F Building C, 2 Shangdi Xinxi Road
MedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Doi:10.1021/om401184n
(2014)Doi:10.1016/S0031-9422(00)00473-8
(2001)Doi:10.1002/chem.201403161
(2014)Doi:10.1016/j.catcom.2013.12.012
(2014)Doi:10.1248/cpb.42.739
(1994)Doi:10.1016/S0040-4039(00)61549-6
(1993)